Keros Therapeutics Inc
(NASDAQ:KROS)
$30.48
0.14[0.46%]
Last update: 2:32PM (Delayed 15-Minutes)
Get Real Time Here
$30.34
-0.1400[-0.46%]
After-Hours
PerksBuyCompare Brokers
Open30.330Close-
Vol / Avg.81.255K / 238.673KMkt Cap913.162M
Day Range29.890 - 31.97052 Wk Range27.020 - 59.960

Keros Therapeutics Stock (NASDAQ:KROS), Quotes and News Summary

Keros Therapeutics Stock (NASDAQ: KROS) stock price, news, charts, stock research, profile.

Open30.330Close-
Vol / Avg.81.255K / 238.673KMkt Cap913.162M
Day Range29.890 - 31.97052 Wk Range27.020 - 59.960
Lisa Levin - Jun 9, 2023, 12:49PM
Lisa Levin - Oct 10, 2022, 11:42AM
Lisa Levin - May 19, 2022, 4:45AM
Vandana Singh - May 18, 2022, 12:38PM
Vandana Singh - May 18, 2022, 12:25PM
Vandana Singh - May 18, 2022, 10:15AM
Shanthi Rexaline - Dec 6, 2021, 6:07AM
Lisa Levin - Nov 5, 2021, 5:01AM
Lisa Levin - Sep 28, 2021, 5:07AM
Lisa Levin - Sep 27, 2021, 12:00PM
Globe Newswire - Nov 7, 2023, 8:00AM
Globe Newswire - Nov 6, 2023, 8:00AM
Globe Newswire - Nov 2, 2023, 9:00AM
Globe Newswire - Oct 4, 2023, 8:00AM
Globe Newswire - Sep 5, 2023, 8:00AM
Globe Newswire - Aug 7, 2023, 8:00AM
Globe Newswire - Jul 27, 2023, 4:01PM
Globe Newswire - Jul 24, 2023, 8:00AM
Globe Newswire - Jun 12, 2023, 8:00AM
Globe Newswire - Jun 9, 2023, 6:00AM
Full archive of press releases available on Benzinga Pro
TipRanks - 1 day ago
TipRanks - Nov 13, 2023, 6:45AM
TipRanks - Nov 8, 2023, 9:50PM
TipRanks - Nov 8, 2023, 12:30AM
TipRanks - Nov 7, 2023, 6:40AM
TipRanks - Nov 7, 2023, 6:29AM
TipRanks - Nov 6, 2023, 6:10PM
Seeking Alpha - Nov 6, 2023, 1:19PM
TipRanks - Nov 6, 2023, 1:00AM
TipRanks - Oct 26, 2023, 7:34AM
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q4 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q3 2023Est.ActualSurprise
EPS-1.350-1.330 0.0200
REV8.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-11-13WedbushAndreas ArgyridesReiteratesOutperformOutperformMaintains-86.00
2023-08-31WedbushAndreas ArgyridesReiteratesOutperformOutperformMaintains-86.00
2023-08-09HC Wainwright & Co.Andrew FeinReiteratesBuyBuyMaintains-100.00
2023-08-08WedbushAndreas ArgyridesReiteratesOutperformOutperformMaintains-86.00

Related Companies

TickerCompanyChg %Mkt Cap
KROSKeros Therapeutics0.46%913.2M
VALNValneva-1%798.3M
ZNTLZentalis Pharma-1.33%785.5M
DAWNDay One Biopharmaceutical3.02%1B
XNCRXencor0.11%1.1B
Q

How do I buy Keros Therapeutics (KROS) stock?

A

You can purchase shares of Keros Therapeutics (NASDAQ: KROS) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Keros Therapeutics's (KROS) competitors?

A

Other companies in Keros Therapeutics’s space includes: Valneva (NASDAQ:VALN), Zentalis Pharma (NASDAQ:ZNTL), Day One Biopharmaceutical (NASDAQ:DAWN), Xencor (NASDAQ:XNCR) and Tango Therapeutics (NASDAQ:TNGX).

Q

What is the target price for Keros Therapeutics (KROS) stock?

A

The latest price target for Keros Therapeutics (NASDAQ: KROS) was reported by Wedbush on Monday, November 13, 2023. The analyst firm set a price target for 86.00 expecting KROS to rise to within 12 months (a possible 182.15% upside). 13 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Keros Therapeutics (KROS)?

A

The stock price for Keros Therapeutics (NASDAQ: KROS) is $30.48 last updated Today at December 1, 2023 at 7:32 PM UTC.

Q

Does Keros Therapeutics (KROS) pay a dividend?

A

There is no dividend information for Keros Therapeutics.

Q

When is Keros Therapeutics (NASDAQ:KROS) reporting earnings?

A

Keros Therapeutics’s Q4 earnings are confirmed for Friday, March 1, 2024.

Q

Is Keros Therapeutics (KROS) going to split?

A

There is no upcoming split for Keros Therapeutics.

Q

What sector and industry does Keros Therapeutics (KROS) operate in?

A

Keros Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.